New compound shows promise in treating multiple human cancers
A new compound, discovered jointly by international pharmaceutical company Servier, headquartered in France, and Vernalis…
Author ONA Editor
ONA Editor
The ONA Editor curates oncology news, views and reviews from Australia and around the world for our readers. In aggregated content, original sources will be acknowledged in the article footer.
Breast self-examination: should you really ‘pledge to check’?
Brett Montgomery, University of Western Australia Shopping at my local pharmacy last week, I was…
We could prevent millions of cancer deaths each year with knowledge we already have
David Hunter, Harvard University. Vice President Joe Biden’s Cancer Moonshot Blue Ribbon Panel has released…
Factors of metabolic dysfunction are associated with increased risk for liver cancer
High body mass index (BMI), increased waist circumference and type 2 diabetes mellitus were associated…
Safety of selenium for colorectal cancer questioned
A 12-year study led by a team of University of Arizona Cancer Center researchers is…
Long-term experience supports efficacy and safety of PRRT for treating neuroendocrine tumours
More than ten years of published clinical data and personal experience using peptide receptor radionuclide…
Roadmap to get new cancer scans into clinic
A team of international scientists has outlined key recommendations for a global standard for scanning…
Faulty molecule offers new target for treating liver cancer
Blocking a single faulty molecule in a biological process that drives the growth of advanced…
Overcoming the evolution of cancer
Cancer evolution can lead to the emergence of drug resistance, so the ICR and The…
Propanolol as an anti-cancer drug
Propranolol, a beta-blocker commonly prescribed to treat irregular heart rates and other conditions, has significant…